Skip to main content
Clinical Trials/NCT05607381
NCT05607381RecruitingNot Applicable

Neural Mechanisms of Meditation-Based Interventions for Chronic Low Back Pain

University of Utah2 sites in 1 country188 target enrollmentStarted: November 30, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
188
Locations
2
Primary Endpoint
Blood oxygenation level dependent (BOLD) signaling

Study Overview

Brief Summary

The purpose of this research study is to see how a mindfulness meditation-based intervention affects pain. Specifically, we are interested in understanding the pain-relieving brain mechanisms of mindfulness meditation-based therapy for patients with opioid-treated chronic low back pain.

Detailed Description

The trial is powered to detect an effect on the primary outcome with 150 participants with complete pre-post data; additional participants are enrolled to account for approximately 25% attrition.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 1) men/women 18-65 years of age; 2) current chronic low back pain classified according to the NIH Pain Consortium task force research standards for chronic low back pain (pain on at least half the days in the past 6 months); usual back pain ≥3 on 0-10 scale with opioid medication; and 4) current use of prescription opioids for ≥3 months.

Exclusion Criteria

  • 1) Prior experience with MBSR, MBCT, MORE, or extensive involvement in any standardized meditation training, 2) current cancer diagnosis, 3) suicide intent or attempt in the past 30 days, 4) psychosis or moderate/severe non-opioid substance use disorder in past 6 months; 5) persons with any electronic objects or certain metal objects in their head or body that are incompatible with MRI; 6) those who have had an abnormal brain MRI in the past; 7) those unable to lie still on their back for 1 to 1.5 hours; and 8) pregnancy.

Arms & Interventions

Mindfulness

Experimental

A well-validated mindfulness meditation-based therapy [8 sessions] is used to teach patients to independently practice meditation to cope with pain.

Intervention: Meditation (Behavioral)

Mindfulness

Experimental

A well-validated mindfulness meditation-based therapy [8 sessions] is used to teach patients to independently practice meditation to cope with pain.

Intervention: Usual care (Other)

Meditation

Experimental

A validated meditation-based therapy [8 sessions] is used to teach patients to independently practice meditation to cope with pain.

Intervention: Meditation (Behavioral)

Meditation

Experimental

A validated meditation-based therapy [8 sessions] is used to teach patients to independently practice meditation to cope with pain.

Intervention: Usual care (Other)

Usual Care

Active Comparator

Patients will receive usual medical care for chronic low back pain.

Intervention: Usual care (Other)

Outcomes

Primary Outcomes

Blood oxygenation level dependent (BOLD) signaling

Time Frame: At baseline and at post-treatment (8 weeks)

Changes in blood oxygenation levels to thermally noxious stimuli (48°C) will be assessed.

Secondary Outcomes

  • Pain catastrophizing(At baseline, post-treatment (8 weeks), and 3-month follow-up)
  • Self-transcendence(At baseline, post-treatment (8 weeks), and 3-month follow-up)
  • Visual Analog Scale Pain Ratings(At baseline and at post-treatment (8 weeks))
  • Chronic pain symptoms(At baseline, post-treatment (8 weeks), and 3-month follow-up)
  • Opioid dose(At baseline, post-treatment (8 weeks), and 3-month follow-up)
  • Mindful reinterpretation of pain sensations(At baseline, post-treatment (8 weeks), and 3-month follow-up)
  • Trait mindfulness(At baseline, post-treatment (8 weeks), and 3-month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Eric Garland

Associate Dean for Research

University of Utah

Study Sites (2)

Loading locations...

Similar Trials